HEADER CELL CYCLE 26-FEB-10 2X7E TITLE CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (R)-FLUORASTROL COMPND MOL_ID: 1; COMPND 2 MOLECULE: KINESIN-LIKE PROTEIN KIF11; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MOTOR DOMAIN, RESIDUES 1-368; COMPND 5 SYNONYM: KINESIN-RELATED MOTOR PROTEIN EG5, KINESIN-LIKE SPINDLE COMPND 6 PROTEIN HKSP, THYROID RECEPTOR-INTERACTING PROTEIN 5, KINESIN-LIKE COMPND 7 PROTEIN 1, TRIP-5; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PLYSS KEYWDS MICROTUBULE, ATP-BINDING, MOTOR PROTEIN, CELL DIVISION, MITOSIS, KEYWDS 2 INHIBITOR, CELL CYCLE, NUCLEOTIDE-BINDING, KSP EXPDTA X-RAY DIFFRACTION AUTHOR H.Y.K.KAAN,V.ULAGANATHAN,O.RATH,C.LAGGNER,H.PROKOPCOVA,D.DALLINGER, AUTHOR 2 C.O.KAPPE,F.KOZIELSKI REVDAT 3 20-DEC-23 2X7E 1 REMARK LINK REVDAT 2 21-SEP-11 2X7E 1 JRNL REMARK VERSN REVDAT 1 14-JUL-10 2X7E 0 JRNL AUTH H.Y.K.KAAN,V.ULAGANATHAN,O.RATH,H.PROKOPCOVA,D.DALLINGER, JRNL AUTH 2 C.O.KAPPE,F.KOZIELSKI JRNL TITL STRUCTURAL BASIS FOR INHIBITION OF EG5 BY JRNL TITL 2 DIHYDROPYRIMIDINES: STEREOSELECTIVITY OF ANTIMITOTIC JRNL TITL 3 INHIBITORS ENASTRON, DIMETHYLENASTRON AND FLUORASTROL. JRNL REF J.MED.CHEM. V. 53 5676 2010 JRNL REFN ISSN 0022-2623 JRNL PMID 20597485 JRNL DOI 10.1021/JM100421N REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 32139 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1709 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2239 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.2080 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5244 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 336 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : -1.23000 REMARK 3 B33 (A**2) : 0.85000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.386 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.287 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.190 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.972 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5508 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7481 ; 1.819 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 683 ; 7.393 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 245 ;36.237 ;24.163 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1001 ;19.300 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;18.089 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 871 ; 0.124 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4073 ; 0.014 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3352 ; 1.228 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5469 ; 2.293 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2156 ; 3.486 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2002 ; 5.714 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 2X7E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1290043038. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35497 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 93.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1X88 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG3350, 0.2M K2HPO4, 0.1M HEPES REMARK 280 PH8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.79850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.03150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.92450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 80.03150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.79850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.92450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 LYS A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 GLY A 16 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 GLY A 276 REMARK 465 ALA A 277 REMARK 465 VAL A 278 REMARK 465 ASP A 279 REMARK 465 LYS A 280 REMARK 465 ARG A 281 REMARK 465 ALA A 282 REMARK 465 ARG A 283 REMARK 465 GLU A 284 REMARK 465 ALA A 285 REMARK 465 GLY A 286 REMARK 465 VAL A 365 REMARK 465 ASN A 366 REMARK 465 GLN A 367 REMARK 465 LYS A 368 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 PRO B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 ALA B 9 REMARK 465 LYS B 10 REMARK 465 LYS B 11 REMARK 465 LYS B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 LYS B 15 REMARK 465 GLY B 16 REMARK 465 ILE B 272 REMARK 465 GLY B 273 REMARK 465 ARG B 274 REMARK 465 SER B 275 REMARK 465 GLY B 276 REMARK 465 ALA B 277 REMARK 465 VAL B 278 REMARK 465 ASP B 279 REMARK 465 LYS B 280 REMARK 465 ARG B 281 REMARK 465 ALA B 282 REMARK 465 ARG B 283 REMARK 465 GLU B 284 REMARK 465 ALA B 285 REMARK 465 GLY B 286 REMARK 465 GLN B 367 REMARK 465 LYS B 368 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 192 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 287 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG2 ILE A 288 O HOH A 2132 2.11 REMARK 500 O SER B 175 O HOH B 2065 2.12 REMARK 500 OG SER B 61 NH1 ARG B 63 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL B 178 N - CA - C ANGL. DEV. = 24.7 DEGREES REMARK 500 SER B 179 N - CA - C ANGL. DEV. = -22.3 DEGREES REMARK 500 ARG B 234 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 18 135.21 -38.73 REMARK 500 ALA A 58 -79.60 74.32 REMARK 500 ASN A 122 22.40 83.77 REMARK 500 ASP A 149 28.60 -151.36 REMARK 500 ARG A 234 -13.58 -159.07 REMARK 500 ILE A 288 23.48 103.80 REMARK 500 ASN A 289 96.54 -61.42 REMARK 500 PRO A 310 44.86 -86.45 REMARK 500 SER B 36 60.30 37.82 REMARK 500 LEU B 57 19.05 140.69 REMARK 500 ASP B 59 -16.51 -141.87 REMARK 500 ASP B 59 -19.17 -142.52 REMARK 500 SER B 61 161.94 158.63 REMARK 500 VAL B 178 2.49 -38.44 REMARK 500 ARG B 189 -71.98 -65.90 REMARK 500 PRO B 310 43.47 -78.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2005 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A2050 DISTANCE = 6.59 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 601 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 112 OG1 REMARK 620 2 ADP A 600 O1B 87.7 REMARK 620 3 HOH A2108 O 87.6 174.9 REMARK 620 4 HOH A2124 O 79.9 91.0 86.2 REMARK 620 5 HOH A2168 O 90.9 90.0 92.1 170.8 REMARK 620 6 HOH A2170 O 166.7 91.3 92.8 86.9 102.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 604 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 112 OG1 REMARK 620 2 ADP B 603 O1B 95.4 REMARK 620 3 HOH B2098 O 85.3 176.6 REMARK 620 4 HOH B2115 O 79.0 96.7 80.2 REMARK 620 5 HOH B2160 O 166.4 89.9 88.7 87.9 REMARK 620 6 HOH B2162 O 89.7 91.6 91.7 166.5 102.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X7E A 1365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X7E B 1365 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1II6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 IN COMPLEXWITH MG-ADP. REMARK 900 RELATED ID: 2FKY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 13 REMARK 900 RELATED ID: 2UYI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH ADP AND THIOPHENE REMARK 900 CONTAINING INHIBITOR 33 REMARK 900 RELATED ID: 1Q0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MOTOR PROTEIN KSP IN COMPLEX WITHADP AND REMARK 900 MONASTROL REMARK 900 RELATED ID: 2WOG RELATED DB: PDB REMARK 900 EG5-INHIBITOR COMPLEX REMARK 900 RELATED ID: 2X2R RELATED DB: PDB REMARK 900 EG5-INHIBITOR COMPLEX REMARK 900 RELATED ID: 2G1Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 9H REMARK 900 RELATED ID: 2UYM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH ADP AND THIOPHENE REMARK 900 CONTAINING INHIBITOR 37 REMARK 900 RELATED ID: 1YRS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 1 REMARK 900 RELATED ID: 2FL6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 6 REMARK 900 RELATED ID: 2GM1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 IN COMPLEXWITH MG-ADP REMARK 900 AND N-(3- AMINOPROPYL)-N-((3-BENZYL-5-CHLORO-4-OXO- 3,4- REMARK 900 DIHYDROPYRROLO[2,1-F][1,2,4] TRIAZIN-2-YL)(CYCLOPROPYL)METHYL)-4- REMARK 900 METHYLBENZAMIDE REMARK 900 RELATED ID: 1X88 RELATED DB: PDB REMARK 900 HUMAN EG5 MOTOR DOMAIN BOUND TO MG-ADP AND MONASTROL REMARK 900 RELATED ID: 2FL2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 19 REMARK 900 RELATED ID: 2X7C RELATED DB: PDB REMARK 900 EG5-INHIBITOR A COMPLEX REMARK 900 RELATED ID: 2X7D RELATED DB: PDB REMARK 900 EG5-INIHIBITOR B COMPLEX DBREF 2X7E A 1 368 UNP P52732 KIF11_HUMAN 1 368 DBREF 2X7E B 1 368 UNP P52732 KIF11_HUMAN 1 368 SEQRES 1 A 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 A 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 A 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 A 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 A 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 A 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 A 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 A 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 A 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 A 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 A 368 PRO LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 A 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 A 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 A 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 A 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 A 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 A 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 A 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 A 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 A 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 A 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 A 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 A 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 A 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 A 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 A 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 A 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 A 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 A 368 VAL ASN GLN LYS SEQRES 1 B 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 B 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 B 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 B 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 B 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 B 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 B 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 B 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 B 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 B 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 B 368 PRO LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 B 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 B 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 B 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 B 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 B 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 B 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 B 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 B 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 B 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 B 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 B 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 B 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 B 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 B 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 B 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 B 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 B 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 B 368 VAL ASN GLN LYS HET ADP A 600 27 HET MG A 601 1 HET X7E A1365 26 HET ADP B 603 27 HET MG B 604 1 HET X7E B1365 26 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM MG MAGNESIUM ION HETNAM X7E (4R)-5-[(S)-(3,4-DIFLUOROPHENYL)(HYDROXY)METHYL]-4-(3- HETNAM 2 X7E HYDROXYPHENYL)-1,6-DIMETHYL-3,4-DIHYDROPYRIMIDINE- HETNAM 3 X7E 2(1H)-THIONE HETSYN X7E (R)-(3,4-DIFLUOROPHENYL)(4-(3-HYDROXYPHENYL)-1,6- HETSYN 2 X7E DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 4 MG 2(MG 2+) FORMUL 5 X7E 2(C19 H18 F2 N2 O2 S) FORMUL 9 HOH *336(H2 O) HELIX 1 1 ASN A 29 ALA A 35 1 7 HELIX 2 2 LYS A 77 VAL A 85 1 9 HELIX 3 3 VAL A 85 MET A 95 1 11 HELIX 4 4 GLY A 110 GLU A 116 1 7 HELIX 5 5 SER A 120 GLU A 124 5 5 HELIX 6 6 THR A 126 ASP A 130 5 5 HELIX 7 7 GLY A 134 LEU A 147 1 14 HELIX 8 8 ASN A 206 ASP A 208 5 3 HELIX 9 9 GLU A 209 MET A 228 1 20 HELIX 10 10 ALA A 230 ARG A 234 5 5 HELIX 11 11 ASN A 289 GLU A 304 1 16 HELIX 12 12 PRO A 310 GLU A 313 5 4 HELIX 13 13 SER A 314 LEU A 320 1 7 HELIX 14 14 GLN A 321 LEU A 324 5 4 HELIX 15 15 ALA A 339 LEU A 341 5 3 HELIX 16 16 ASN A 342 LYS A 357 1 16 HELIX 17 17 ASN B 29 ALA B 35 1 7 HELIX 18 18 LYS B 77 VAL B 85 1 9 HELIX 19 19 VAL B 85 MET B 95 1 11 HELIX 20 20 GLY B 110 GLU B 116 1 7 HELIX 21 21 SER B 120 GLU B 124 5 5 HELIX 22 22 GLY B 134 THR B 148 1 15 HELIX 23 23 ASN B 206 ASP B 208 5 3 HELIX 24 24 GLU B 209 MET B 228 1 20 HELIX 25 25 ALA B 230 SER B 235 1 6 HELIX 26 26 ASN B 289 ARG B 305 1 17 HELIX 27 27 PRO B 310 GLU B 313 5 4 HELIX 28 28 SER B 314 LEU B 320 1 7 HELIX 29 29 GLN B 321 LEU B 324 5 4 HELIX 30 30 ALA B 339 LEU B 341 5 3 HELIX 31 31 ASN B 342 LYS B 357 1 16 SHEET 1 AA 8 MET A 70 PHE A 72 0 SHEET 2 AA 8 GLN A 20 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AA 8 ARG A 329 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AA 8 ASN A 98 GLY A 105 1 O ASN A 98 N ARG A 329 SHEET 5 AA 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AA 8 HIS A 236 THR A 248 -1 O SER A 237 N ASP A 265 SHEET 7 AA 8 THR A 152 TYR A 164 -1 O GLU A 153 N LYS A 246 SHEET 8 AA 8 GLU A 167 ASP A 170 -1 O GLU A 167 N TYR A 164 SHEET 1 AB 8 MET A 70 PHE A 72 0 SHEET 2 AB 8 GLN A 20 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AB 8 ARG A 329 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AB 8 ASN A 98 GLY A 105 1 O ASN A 98 N ARG A 329 SHEET 5 AB 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AB 8 HIS A 236 THR A 248 -1 O SER A 237 N ASP A 265 SHEET 7 AB 8 THR A 152 TYR A 164 -1 O GLU A 153 N LYS A 246 SHEET 8 AB 8 ILE A 202 VAL A 204 -1 O ILE A 202 N VAL A 158 SHEET 1 AC 2 GLU A 167 ASP A 170 0 SHEET 2 AC 2 THR A 152 TYR A 164 -1 O GLU A 162 N PHE A 169 SHEET 1 AD 3 VAL A 41 ASP A 44 0 SHEET 2 AD 3 GLU A 49 GLY A 55 -1 O GLU A 49 N ASP A 44 SHEET 3 AD 3 SER A 62 THR A 67 -1 O SER A 62 N THR A 54 SHEET 1 AE 2 GLN A 183 ASP A 187 0 SHEET 2 AE 2 ASN A 190 LYS A 197 -1 N ASN A 190 O ASP A 187 SHEET 1 BA 8 MET B 70 PHE B 72 0 SHEET 2 BA 8 GLN B 20 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BA 8 ARG B 329 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BA 8 ASN B 98 GLY B 105 1 O ASN B 98 N ARG B 329 SHEET 5 BA 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BA 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BA 8 THR B 152 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BA 8 GLU B 167 ASP B 170 -1 O GLU B 167 N TYR B 164 SHEET 1 BB 8 MET B 70 PHE B 72 0 SHEET 2 BB 8 GLN B 20 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BB 8 ARG B 329 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BB 8 ASN B 98 GLY B 105 1 O ASN B 98 N ARG B 329 SHEET 5 BB 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BB 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BB 8 THR B 152 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BB 8 ILE B 202 VAL B 204 -1 O ILE B 202 N VAL B 158 SHEET 1 BC 2 GLU B 167 ASP B 170 0 SHEET 2 BC 2 THR B 152 TYR B 164 -1 O GLU B 162 N PHE B 169 SHEET 1 BD 3 VAL B 41 ASP B 44 0 SHEET 2 BD 3 GLU B 49 ARG B 53 -1 O GLU B 49 N ASP B 44 SHEET 3 BD 3 ARG B 63 THR B 67 -1 O LYS B 64 N VAL B 52 SHEET 1 BE 2 GLN B 183 ASP B 186 0 SHEET 2 BE 2 VAL B 194 LYS B 197 -1 O ILE B 195 N PHE B 185 LINK OG1 THR A 112 MG MG A 601 1555 1555 2.06 LINK O1B ADP A 600 MG MG A 601 1555 1555 2.01 LINK MG MG A 601 O HOH A2108 1555 1555 2.07 LINK MG MG A 601 O HOH A2124 1555 1555 2.17 LINK MG MG A 601 O HOH A2168 1555 1555 1.89 LINK MG MG A 601 O HOH A2170 1555 1555 2.14 LINK OG1 THR B 112 MG MG B 604 1555 1555 2.18 LINK O1B ADP B 603 MG MG B 604 1555 1555 1.85 LINK MG MG B 604 O HOH B2098 1555 1555 2.05 LINK MG MG B 604 O HOH B2115 1555 1555 2.17 LINK MG MG B 604 O HOH B2160 1555 1555 2.19 LINK MG MG B 604 O HOH B2162 1555 1555 1.91 SITE 1 AC1 17 ARG A 24 ARG A 26 PRO A 27 THR A 107 SITE 2 AC1 17 GLY A 108 THR A 109 GLY A 110 LYS A 111 SITE 3 AC1 17 THR A 112 PHE A 113 GLU A 118 MG A 601 SITE 4 AC1 17 HOH A2046 HOH A2124 HOH A2168 HOH A2169 SITE 5 AC1 17 HOH A2170 SITE 1 AC2 6 THR A 112 ADP A 600 HOH A2108 HOH A2124 SITE 2 AC2 6 HOH A2168 HOH A2170 SITE 1 AC3 18 ARG B 24 ARG B 26 PRO B 27 THR B 107 SITE 2 AC3 18 GLY B 108 THR B 109 GLY B 110 LYS B 111 SITE 3 AC3 18 THR B 112 PHE B 113 GLU B 118 MG B 604 SITE 4 AC3 18 HOH B2115 HOH B2160 HOH B2161 HOH B2162 SITE 5 AC3 18 HOH B2163 HOH B2164 SITE 1 AC4 6 THR B 112 ADP B 603 HOH B2098 HOH B2115 SITE 2 AC4 6 HOH B2160 HOH B2162 SITE 1 AC5 15 GLU A 116 GLY A 117 GLU A 118 ARG A 119 SITE 2 AC5 15 ASP A 130 ALA A 133 PRO A 137 LEU A 160 SITE 3 AC5 15 TYR A 211 LEU A 214 GLY A 217 ALA A 218 SITE 4 AC5 15 ARG A 221 PHE A 239 HOH A2171 SITE 1 AC6 13 GLU B 116 GLY B 117 GLU B 118 ARG B 119 SITE 2 AC6 13 ASP B 130 ALA B 133 PRO B 137 LEU B 160 SITE 3 AC6 13 TYR B 211 LEU B 214 GLY B 217 ARG B 221 SITE 4 AC6 13 PHE B 239 CRYST1 69.597 79.849 160.063 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014368 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012524 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006248 0.00000